Baird Financial Group
BIO icon

Baird Financial Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Baird Financial Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,634
Closed -$4.82M – 1753
2024
Q2 		$4.82M Buy
17,634
+1,542
+10% +$448K 0.01% 676
2024
Q1 		$5.57M Buy
16,092
+3,921
+32% +$1.29M 0.01% 632
2023
Q4 		$3.93M Sell
12,171
-1,700
-12% -$533K 0.01% 732
2023
Q3 		$4.97M Buy
13,871
+1,034
+8% +$399K 0.01% 628
2023
Q2 		$4.87M Buy
12,837
+10,077
+365% +$4.1M 0.01% 630
2023
Q1 		$1.32M Buy
2,760
+367
+15% +$172K ﹤0.01% 1018
2022
Q4 		$1.01M Buy
2,393
+88
+4% +$35.5K ﹤0.01% 1065
2022
Q3 		$962K Buy
2,305
+126
+6% +$62.8K ﹤0.01% 1063
2022
Q2 		$1.08M Buy
2,179
+184
+9% +$95.8K ﹤0.01% 1053
2022
Q1 		$1.12M Buy
1,995
+203
+11% +$122K ﹤0.01% 1098
2021
Q4 		$1.35M Buy
1,792
+293
+20% +$219K ﹤0.01% 1089
2021
Q3 		$1.12M Buy
1,499
+1,048
+232% +$785K ﹤0.01% 1161
2021
Q2 		$291K Sell
451
-54
-11% -$32.9K ﹤0.01% 1583
2021
Q1 		$289K Buy
+505
New +$299K ﹤0.01% 1534
2019
Q4 		– Sell
-7,099
Closed -$2.36M – 1509
2019
Q3 		$2.36M Buy
+7,099
New +$2.32M 0.01% 726

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Baird Financial Group's BIO Position: Q3 2024 in Review

Baird Financial Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 17,634 shares — an estimated $4.82M sold.

Baird Financial Group first reported a position in BIO in Q3 2019 and held it in 15 quarters. The position peaked at $5.57M in Q1 2024. 438 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • Baird Financial Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • Baird Financial Group sold 17,634 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $4.82M.
  • Baird Financial Group first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 15 quarters.
  • Baird Financial Group's Bio-Rad Laboratories Class A position peaked at $5.57M in Q1 2024.
  • 438 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on Baird Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.